Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Pfizer
Tizona Therapeutics, Inc
Novartis
Molecure S.A.
Astellas Pharma Inc
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Canadian Cancer Trials Group
Janssen Research & Development, LLC
Quadriga Biosciences, Inc.
Imperial College London
Pfizer
Weill Medical College of Cornell University
Celldex Therapeutics
Celgene
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Santa Maria Biotherapeutics
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
Indiana University
University of Chicago
Altor BioScience
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Eisai Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Takeda
Astellas Pharma Inc
Pharmacyclics LLC.